Comments on: Roy Wins WE-REACH Go-To-Market Award for Novel Drug to Treat Idiopathic Pulmonary Fibrosis (IPF) /we-reach/2022/05/02/roy-wins-we-reach-go-to-market-award-for-novel-drug-to-treat-idiopathic-pulmonary-fibrosis-ipf/ Washington Entrepreneurial Research Evaluation and Commercialization Hub Mon, 02 May 2022 20:54:54 +0000 hourly 1 https://wordpress.org/?v=6.9.4